Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)

Status:
Completed

Trial end date:
2020-07-31

Target enrollment:

Participant gender:

A multicenter, randomized, open-label, active-controlled Phase 3 study for the maintenance treatment of anemia in subjects with NDD-CKD

Phase 3

Akebia Therapeutics

Darbepoetin alfa